Telix Files TLX250-CDx (Zircaix®) BLA for Kidney Cancer Imaging
MELBOURNE,Australia and INDIANAPOLIS,Dec. 30,2024-- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX,Telix,the Company) today announces that it has submitted its Biologics License Application (BL